139 related articles for article (PubMed ID: 31452800)
21. Proto-oncogene RTL4 promotes tumorigenesis and invasiveness of papillary thyroid cancer.
Kong L; Bhandari A; Zhang X; Wang O
Am J Transl Res; 2020; 12(6):3023-3032. PubMed ID: 32655827
[TBL] [Abstract][Full Text] [Related]
22. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
23. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
Wang R; Zhao L; Ji L; Bai L; Wen Q
Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
[TBL] [Abstract][Full Text] [Related]
24. Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.
Mohamad Yusof A; Jamal R; Muhammad R; Abdullah Suhaimi SN; Mohamed Rose I; Saidin S; Ab Mutalib NS
Front Endocrinol (Lausanne); 2018; 9():158. PubMed ID: 29713312
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
26. MiR-324-5p assists ultrasonography in predicting lymph node metastasis of unifocal papillary thyroid microcarcinoma without extracapsular spread.
Yang Y; Xia S; Ni X; Ni Z; Zhang L; Wang W; Kong Y; Wang Y; Ye L; Zhan W
Oncotarget; 2017 Oct; 8(48):83802-83816. PubMed ID: 29137384
[TBL] [Abstract][Full Text] [Related]
27. TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer.
Cai Z; Zhai T; Muhanhali D; Ling Y
Int J Endocrinol; 2021; 2021():6686998. PubMed ID: 33564303
[TBL] [Abstract][Full Text] [Related]
28. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
29. Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion.
Yang X; Li Y; Liu G; Zha W; Liu Y
Oncol Lett; 2022 May; 23(5):145. PubMed ID: 35350592
[TBL] [Abstract][Full Text] [Related]
30. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
[TBL] [Abstract][Full Text] [Related]
32. LINC00891 promotes tumorigenesis and metastasis of thyroid cancer by regulating SMAD2/3 via EZH2.
Si Y; Wen J; Hu C; Chen H; Lin L; Xu Y; Ren D; Meng X; Wang Y; Xia E; Bhandari A; Wang O
Curr Med Chem; 2023 May; ():. PubMed ID: 37221682
[TBL] [Abstract][Full Text] [Related]
33. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
34. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
[TBL] [Abstract][Full Text] [Related]
35. The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.
Fu XM; Guo W; Li N; Liu HZ; Liu J; Qiu SQ; Zhang Q; Wang LC; Li F; Li CL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3239-3246. PubMed ID: 28770959
[TBL] [Abstract][Full Text] [Related]
36. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
[TBL] [Abstract][Full Text] [Related]
37. Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma.
Jin YX; Zhou XF; Chen YY; Jin WX; Wang YH; Ye DR; Sun YH; Li YF; Wang QX; Zhang XH; Wang OC; Chen ED
J Cancer; 2019; 10(15):3543-3552. PubMed ID: 31293659
[No Abstract] [Full Text] [Related]
38. PKHD1L1 is required for stereocilia bundle maintenance, durable hearing function and resilience to noise exposure.
Strelkova OS; Osgood RT; Tian CJ; Zhang X; Hale E; De-la-Torre P; Hathaway DM; Indzhykulian AA
bioRxiv; 2024 Mar; ():. PubMed ID: 38496629
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.
Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M
Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505
[TBL] [Abstract][Full Text] [Related]
40.
Yin Y; Hong S; Yu S; Huang Y; Chen S; Liu Y; Zhang Q; Li Y; Xiao H
Int J Endocrinol; 2017; 2017():6180425. PubMed ID: 28740507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
